XEN1101, a novel, potent potassium channel modulator: Interim data from an ongoing, long-term, open-label extension of a Phase 2b study (X-TOLE) in adults with focal onset seizures (FOS)

Authors
Category Primary study
Conference15th European Epilepsy Congress, EEC 2024
Year 2024
This article has no abstract
Epistemonikos ID: 35cc3c3d7a881ee53d92e1e09665059913cd6bfe
First added on: Feb 14, 2026